We are live on
!
Find out more
LCM
Legato Capital Management Portfolio holdings
AUM
$1.1B
1-Year Est. Return
61.65%
This Fund
S&P 500
This Quarter
Est. Return
+16.16%
1 Year Est. Return
+61.65%
3 Year Est. Return
+176.99%
5 Year Est. Return
+237.89%
10 Year Est. Return
+625.59%
AUM
$918M
AUM Growth
+$78.7M
(+9.4%)
Cap. Flow
-$9.19M
Cap. Flow
% of AUM
-1%
Top 10 Holdings %
Top 10 Hldgs %
12.06%
Holding
631
New
69
Increased
135
Reduced
112
Closed
73
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visteon
VC
|
+$2.62M |
| 2 |
Symbotic
SYM
|
+$2.58M |
| 3 |
Climb Global Solutions
CLMB
|
+$2.58M |
| 4 |
Adobe
ADBE
|
+$1.81M |
| 5 |
Construction Partners
ROAD
|
+$1.77M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.62M |
| 2 |
VRNA
Verona Pharma
VRNA
|
+$3.24M |
| 3 |
Sunstone Hotel Investors
SHO
|
+$2.69M |
| 4 |
Bank of America
BAC
|
+$2.21M |
| 5 |
Amgen
AMGN
|
+$2.19M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.75% |
| 2 | Industrials | 21.74% |
| 3 | Healthcare | 15.84% |
| 4 | Consumer Discretionary | 10.72% |
| 5 | Financials | 10.68% |
Similar funds
PRS
DAM
MAM
PHS
DAM
KCM
AC
YL
Legato Capital Management's Q3 2025 Portfolio in Review
As of Q3 2025, Legato Capital Management held 631 positions worth $918M, up 9.4% from $839M the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Legato Capital Management's Q3 2025 filing shows 69 new, 135 increased, 112 reduced and 73 closed positions. Its largest new stake was Visteon: 22,225 shares worth $2.66M. The largest sale was Broadcom, an estimated $3.62M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Industrials and Healthcare.
- Legato Capital Management's largest Q3 2025 buy was Visteon: 22,225 shares worth $2.66M.
- Legato Capital Management added most to Construction Partners in Q3 2025, an estimated $1.77M increase.
- Legato Capital Management's biggest Q3 2025 reduction was Broadcom, cutting an estimated $3.62M.
- Legato Capital Management fully exited Verona Pharma in Q3 2025, selling an estimated $3.24M.
- Legato Capital Management's ten largest holdings make up 12% of its $918M portfolio in Q3 2025.
- Legato Capital Management opened 69 new positions and closed 73 in Q3 2025.
- Legato Capital Management's portfolio value rose 9.4% quarter-over-quarter to $918M.
Based on Legato Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.